Mérieux Equity Partners Announces the Exit of a Majority of its Stake in Swixx Biopharma

Mérieux Equity Partners is pleased to announce that it has completed the exit of a majority of its stake in Swixx Biopharma, a portfolio company of Mérieux Participations 4 (“MP4”), to SK Capital Partners and Bain Capital Life Sciences.